State Health Plan: Solodyn™ (extended release minocycline) Step Therapy Program
Starting November 1, 2010, brand name Solodyn™ will require a coverage review. Generic minocycline products will not require a coverage review.
The State Health Plan is implementing this program to maintain an affordable prescription drug benefit and to promote the use of generics and preferred medications. Please consider if generic medications may be appropriate for your patients.
Coverage will be approved for Solodyn for patients who are being treated for inflammatory lesions in non-nodular, moderate to severe, acne vulgaris -- and where the patient has experienced intolerance to at least two generically available minocycline products.
Providers may call Medco toll-free at 1-800-417-1764, from 8 a.m. to 9 p.m., Eastern Time, Monday through Friday, to request a review. Members will be responsible for the full cost of the prescription if the provider does not receive approval during the coverage review.
Please visit the Plan website at www.shpnc.org for further information.